VITL Raises $7.5 Million in Series A Funding
VITL, a Nashville-based company, announced on March 27, 2026, that it has raised $7.5 million in a Series A funding round. The round was led by SignalFire. Founded by Charlie Jordan, VITL offers an e-prescribing platform that consolidates compounding pharmacies, allowing users to compare medications, track orders in real-time, and manage prescriptions across a pharmacy network efficiently.
Lead Investor: SignalFire
SignalFire has taken the lead in this Series A funding round, demonstrating confidence in VITL's innovative approach to managing pharmacy networks. The investment signifies a strong endorsement of VITL's technology and its potential to streamline pharmacy operations.
Plans for the New Funding
VITL plans to utilize the newly acquired funds to enhance its platform capabilities and expand its market reach. This includes developing new features that will further simplify the prescription management process and potentially expand into new geographic areas. By improving its technology, VITL aims to offer even more robust solutions to its users, ensuring that pharmacies can operate more efficiently and effectively.
Company Vision
With this funding, VITL is poised to strengthen its position in the healthcare technology space. Charlie Jordan, Founder of VITL, is focused on leveraging this investment to drive innovation and improve the overall experience for pharmacies and their clients. As the healthcare sector continues to evolve, VITL's platform could play a crucial role in transforming how pharmacies operate, offering a unified solution for prescription management.
As the Series A funding round concludes, VITL is set to embark on the next phase of its journey, aiming to make significant strides in the e-prescribing market.